Skip to main content
. 2021 Jun 5;13(11):2824. doi: 10.3390/cancers13112824

Figure 7.

Figure 7

(AF). Disease-free interval (DFI), progression-free interval (PFI), and overall survival (OS) according to breast cancer subtypes (AC), and in HER2-low/HR+ versus HER2-low/HR− breast tumors (DF). Abbreviations: HR: hormone receptor.